Drug recall

Apheresis Red Blood Cells, Leukocytes Reduced

FDA recall event 73515 · Class II · Medic Inc

Key facts

Event ID 73515
Recall numbers B-0365-16
Recalling firm Medic Inc
Product type Biologics
Products Apheresis Red Blood Cells, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Apheresis products, for which quality control testing for residual white blood cell count was not performed, were distributed.
Initiation date Feb 2, 2016
Report date Mar 30, 2016
Termination date Mar 22, 2016
City Knoxville
State TN
Country United States
FEI number 1077605

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls